Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors

Transplantation
Linda D SharplesJohn Wallwork

Abstract

Given the internationally recognized definition of bronchiolitis obliterans syndrome (BOS) and longer follow up of heart-lung transplant recipients, it is possible to establish some of the major risk factors for development and progression of BOS. Between April 1984 and 31 December 1993, 157 patients underwent heart-lung transplantation; 126 survived at least six months after operation and so were at risk of developing BOS. The following early risk factors were assessed for development of BOS grade 1 (21-35% decline in FEV1) and progression from grade 1 to grade 2 (36-50% decline in FEV1): age, gender and underlying diagnosis of the recipient, evidence of acute rejection and cytomegalovirus (CMV) infection within 6 months of operation, peak FEV1 achieved, age and gender of the donor, cold ischemic time of the graft, and matching of CMV serological status and HLA antigens of donor and recipient. The number of acute rejection episodes observed remained the single most important determinant of development of BOS grade 1 (relative risk 1.17 (1.06, 1.29), P=0.002) and progression to BOS grade 2 (relative risk 1.58 (1.02, 2.46), P=0.03). No other factors were significantly related to development or progression of BOS, although both e...Continue Reading

References

Feb 1, 1992·Journal of Cardiothoracic and Vascular Anesthesia·D Royston
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M I HertzP B Bitterman
Apr 1, 1991·Journal of Pediatric Surgery·V A StarnesN E Shumway
May 1, 1990·Transplantation·S A YousemR Hardesty
Mar 15, 1990·The New England Journal of Medicine·J Theodore, N Lewiston
Feb 1, 1989·The American Review of Respiratory Disease·J D CooperJ Maurer
Sep 1, 1985·Human Pathology·S A YousemM E Billingham
Mar 11, 1982·The New England Journal of Medicine·B A ReitzN E Shumway
May 1, 1993·The American Journal of Surgical Pathology·S A Yousem

❮ Previous
Next ❯

Citations

Jun 29, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Wim A WuytsGeert M Verleden
Jan 5, 2000·The Annals of Thoracic Surgery·V A StarnesM L Barr
Nov 20, 1997·Transplantation Proceedings·A PavieI Gandjbakhch
Jun 24, 1998·Transplantation Proceedings·A ZuckermannW Klepetko
Jun 26, 1998·Transplant Immunology·A J Matas
Oct 25, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·S N MitrukaG J Burckart
Mar 19, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Marc EstenneSamuel Yousem
Aug 7, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Martin R Zamora
Apr 8, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·L L SchulmanM E Ginsberg
Jun 11, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·A ZuckermannE Wolner
Aug 19, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·D J RossS C Jordan
Aug 19, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·B HausenR E Morris
Nov 24, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·M JonosonoJ A Golden
Apr 15, 1999·Clinical Transplantation·A H TirokeA Haverich
Jan 7, 2005·Seminars in Thoracic and Cardiovascular Surgery·Ramsey R Hachem, Elbert P Trulock
Jan 13, 2006·The New England Journal of Medicine·Aldo T IaconoBartley P Griffith
Apr 17, 2002·Journal of Thoracic Imaging·Jannette Collins
Mar 10, 2001·Transplantation·J W van den BergW van der Bij
Mar 31, 2000·Current Opinion in Pulmonary Medicine·A Boehler, M Estenne
Mar 23, 2004·Archives of Disease in Childhood·M Burch, P Aurora
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·L L SchulmanS Itescu
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·P E SilkoffS Keshavjee
Mar 2, 1999·American Journal of Respiratory and Critical Care Medicine·A N HusainE R Garrity
Jun 14, 2000·American Journal of Respiratory and Critical Care Medicine·J M CharpinD Israël-Biet
Jun 14, 2000·American Journal of Respiratory and Critical Care Medicine·J W van Den BERGE M ten VERGERT
Feb 17, 2001·American Journal of Respiratory and Critical Care Medicine·L L SchulmanS Itescu
Aug 14, 2001·American Journal of Respiratory and Critical Care Medicine·C L AboyounA R Glanville
Aug 7, 2004·American Journal of Respiratory and Critical Care Medicine·Peter M HopkinsAllan R Glanville
May 30, 2003·American Journal of Respiratory and Critical Care Medicine·Scott M PalmerDavid A Schwartz
Apr 9, 2004·American Journal of Respiratory and Critical Care Medicine·Robert M KotloffStephen W Crawford
May 8, 2004·American Journal of Respiratory and Critical Care Medicine·Anthony P KhalifahMichael J Walter
Aug 7, 2004·American Journal of Respiratory and Critical Care Medicine·Michael TammAllan R Glanville

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.